Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Santoni

Showing results (281-290 of 459) with videos related to

Pageof 46
Sort By:
Annals of Translational Medicine|December 7, 2019
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancerRossana Berardi, Matteo Santoni, Silvia Rinaldi, et al.
European Urology|June 14, 2015
Current Histopathologic and Molecular Characterisations of Prostate Cancer: Towards Individualised Prognosis and TherapiesMatteo Santoni, Marina Scarpelli, Roberta Mazzucchelli, et al.
Expert Review of Molecular Diagnostics|October 15, 2019
Liquid biopsy in the clinical management of bladder cancer: current status and future developmentsErik Kouba, Antonio Lopez-Beltran, Rodolfo Montironi, et al.
Carcinogenesis|January 23, 2010
TRPV2 channel negatively controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-dependent mannerMassimo Nabissi, Maria Beatrice Morelli, Consuelo Amantini, et al.
Cancers|June 6, 2020
Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial CarcinomaVeronica Mollica, Alessandro Rizzo, Rodolfo Montironi, et al.
Journal of Neuro-Oncology|April 9, 2013
Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastomaMatteo Santoni, Silvia Scoccianti, Ivan Lolli, et al.
Anticancer Research|November 14, 2013
VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinomaDaniele Minardi, Guendalina Lucarini, Matteo Santoni, et al.
Critical Reviews in Oncology/Hematology|June 19, 2022
Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survivalMatteo Santoni, Fernando Sabino M Monteiro, Francesco Massari, et al.
Oncotarget|November 19, 2016
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapyRossana Berardi, Matteo Santoni, Thomas Newsom-Davis, et al.
Clinical Genitourinary Cancer|January 31, 2024
Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or PazopanibMartina Catalano, Ugo De Giorgi, Davide Bimbatti, et al.
Pageof 46

Showing results (281-290 of 459) with videos related to

Sort By:
Pageof 46
Annals of Translational Medicine|December 7, 2019
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancerRossana Berardi, Matteo Santoni, Silvia Rinaldi, et al.
European Urology|June 14, 2015
Current Histopathologic and Molecular Characterisations of Prostate Cancer: Towards Individualised Prognosis and TherapiesMatteo Santoni, Marina Scarpelli, Roberta Mazzucchelli, et al.
Expert Review of Molecular Diagnostics|October 15, 2019
Liquid biopsy in the clinical management of bladder cancer: current status and future developmentsErik Kouba, Antonio Lopez-Beltran, Rodolfo Montironi, et al.
Carcinogenesis|January 23, 2010
TRPV2 channel negatively controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-dependent mannerMassimo Nabissi, Maria Beatrice Morelli, Consuelo Amantini, et al.
Cancers|June 6, 2020
Current Strategies and Novel Therapeutic Approaches for Metastatic Urothelial CarcinomaVeronica Mollica, Alessandro Rizzo, Rodolfo Montironi, et al.
Journal of Neuro-Oncology|April 9, 2013
Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastomaMatteo Santoni, Silvia Scoccianti, Ivan Lolli, et al.
Anticancer Research|November 14, 2013
VEGF expression and response to sunitinib in patients with metastatic clear cell renal cell carcinomaDaniele Minardi, Guendalina Lucarini, Matteo Santoni, et al.
Critical Reviews in Oncology/Hematology|June 19, 2022
Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survivalMatteo Santoni, Fernando Sabino M Monteiro, Francesco Massari, et al.
Oncotarget|November 19, 2016
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapyRossana Berardi, Matteo Santoni, Thomas Newsom-Davis, et al.
Clinical Genitourinary Cancer|January 31, 2024
Impact of Metastatic Site in Favorable-Risk Renal Cell Carcinoma Receiving Sunitinib or PazopanibMartina Catalano, Ugo De Giorgi, Davide Bimbatti, et al.
Pageof 46